Concepedia

Kentaro Takai

KT

13

Publications

232

Citations

12

H-Index

2013

Active since

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Gifu University

Kanazawa Medical University

Gifu Pharmaceutical University

National Center of Neurology and Psychiatry

Kentaro Takai is an author at Sumitomo Dainippon Pharma (Japan) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2013–2022

13

Publications

13

Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects

Kazutaka Ohi, Daisuke Nishizawa, Shunsuke Sugiyama et al. · The International Journal of Neuropsychopharmacology · 2021 · 25 citations · Full text

Causal associations of intelligence with schizophrenia and bipolar disorder: A Mendelian randomization analysis

Kazutaka Ohi, Kentaro Takai, Ayumi Kuramitsu et al. · European Psychiatry · 2021 · 22 citations · Full text

Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach

Kazutaka Ohi, Daisuke Nishizawa, Shunsuke Sugiyama et al. · Psychological Medicine · 2022 · 22 citations

Discovery of Novel<i>N</i>-Substituted Oxindoles as Selective M<sub>1</sub>and M<sub>4</sub>Muscarinic Acetylcholine Receptors Partial Agonists

Takaaki Sumiyoshi, Takeshi Enomoto, Kentaro Takai et al. · ACS Medicinal Chemistry Letters · 2013 · 21 citations · Full text

Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia

Kazutaka Ohi, Kentaro Takai, Shunsuke Sugiyama et al. · CNS Spectrums · 2021 · 20 citations

Rows per page

1–5 of 13